CAR-T cell therapy of lymphoma: where do we stand? CAR-T will replace allo-SCT – PRO

Novak, Urban (2020). CAR-T cell therapy of lymphoma: where do we stand? CAR-T will replace allo-SCT – PRO. Schweizer Krebsbulletin / Bulletin suisse du cancer, 40(4), pp. 295-299. Istituto oncologico della Svizzera Italiana

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Novak, Urban

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2297-0703

Publisher:

Istituto oncologico della Svizzera Italiana

Language:

German

Submitter:

Rebeka Gerber

Date Deposited:

20 Jan 2021 13:44

Last Modified:

05 Dec 2022 15:43

URI:

https://boris.unibe.ch/id/eprint/150431

Actions (login required)

Edit item Edit item
Provide Feedback